• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Coca-Cola to Phase Out Honest Tea Brand by Year’s End, Citing Supply Chain Challenges

    Vitafoods Europe 2022 Attendance Returns to 2019 Level

    Beyond Raw Launches Concept X Pre-Workout Line

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Cargill’s Stevia Sustainability Program Benchmarked by FSA
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Cargill’s Stevia Sustainability Program Benchmarked by FSA

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Coca-Cola to Phase Out Honest Tea Brand by Year’s End, Citing Supply Chain Challenges

    Vitafoods Europe 2022 Attendance Returns to 2019 Level

    Beyond Raw Launches Concept X Pre-Workout Line

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Cargill’s Stevia Sustainability Program Benchmarked by FSA
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Beyond Raw Launches Concept X Pre-Workout Line

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Xsto Solutions

    Verdure Sciences

    Botanic Healthcare LLC

    Applied Food Sciences, Inc.

    Aiya America, Inc. (Aiya Matcha)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Xsto Solutions

    Verdure Sciences

    Botanic Healthcare LLC

    Applied Food Sciences, Inc.

    Aiya America, Inc. (Aiya Matcha)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Manufacturing Equipment Technology & Trends

    Potent drug products, delivery systems, continuous manufacturing, and digitization drive innovation.

    Manufacturing Equipment Technology & Trends
    Related CONTENT
    • Oral Solids Endure & Evolve
    • Bone & Joint Formulas Provide Foundations for Fitness
    • GOED Releases Updated Omega-3 Ingredient Market Report
    • FDA Plans to Modernize Dietary Supplement Regulations
    • Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction
    By Kristin Brooks, Managing Editor, Contract Pharma03.01.19
    Rapid advances in pharma and biopharma drug development are resulting in an increasing number of complex and niche therapies. This evolution is impacting manufacturing processes and equipment needs. Demand for flexibility continues to be the driving force behind the latest equipment. Small batches of specialized drug products, such as highly potent and cytotoxic drugs that require containment, various drug delivery systems, continuous manufacturing, and digitization are among the main factors impacting manufacturing and equipment. Contract Pharma spoke with leading manufacturing equipment suppliers and contract manufacturers about the latest pharma and biopharma trends, new capabilities, complexities, and customer needs.

    Evolving Pharma/Biopharma Trends
    The continued evolution from mainstream, mass produced pharmaceuticals to more specialized therapies, has required a complete concept change in manufacturing and processes for pharma companies. “Highly specialized products in small quantities and different drug delivery systems present a challenge for pharmaceutical companies,” said Jan Deininger, editor at Optima. “It makes a change in thinking necessary since niche products require a completely different production process than blockbuster pharmaceuticals. Pharmaceutical companies that produce small quantities need flexible machines that can process small batch sizes and different container types. At the same time, it is essential to maintain the high level requirements for product quality and patient safety,” Deininger noted.

    As a result, the demands on the flexibility of equipment systems are increasing. For example, she said smaller batch sizes have to be mastered and different containers such as syringes, vials and cartridges have to be filled on a single line.

    With more niche products coming to market, Tim Saarinen, chief operating officer for Maruho Hatsujyo Innovations (MHI), said, “The number of products and product packaging to achieve different presentations to the end user has been increasing. With fewer blockbuster products and more moderate scale products coming through the pharmaceutical pipeline, companies are more anxious to differentiate products based on customer experiences.”

    Meanwhile, eliminating the risks associated with exposure to highly potent or cytotoxic drugs requires high containment equipment solutions. Kat Jones, PCI’s director of marketing and commercial operations, said one of the largest trends in recent years has been unprecedented growth in the number of molecules being classified as “potent,” primarily driven by the oncology market, as well as therapy areas including pain and CNS disorders. She said, “Such molecules require special handling to protect both operators and the environment, and although historically as an industry we have relied on personal protective equipment (PPE), guidelines including those issued by the International Society for Pharmacoepidemiology (ISPE) indicate that preferred and best practice solutions should include contained engineering equipment whereby the molecules themselves are subject to full containment through the use of technology.”

    Additional industry trends impacting equipment are continuous manufacturing and digitization in an effort to optimize processes. Andreas Mattern, director of product management, Pharma, at Bosch Packaging Technology, added, “The pharmaceutical industry is changing and developing at an unprecedented pace. On the one hand, important developments in biologics, for instance for the treatment of cancer or orphan diseases, are entering the market. On the other hand, the development of continuous manufacturing equipment for oral solid dosage (OSD) is opening new potential for optimum API dosage and faster time-to-market. Moreover, digitization is also gradually entering the world of pharmaceutical production and is about to change the way we work significantly.”

    Digitization, often referred to as Industry 4.0, is a comprehensive automation, business information, and manufacturing execution strategy aimed at improving the industry via the integration of all aspects of production and commerce across a company for greater efficiency. Similarly, the internet of things, or IoT, is a system of interrelated computing devices, mechanical and digital machines, or people that are provided with unique identifiers (UIDs) and the ability to transfer data over a network without requiring human-to-human or human-to-computer interaction.

    Complex Capabilities
    Pharma and Biopharma companies increasingly look for services and capabilities that span R&D through to manufacturing, filling and packaging. Addressing the need for small to large scale manufacturing, isolator technology, integration options for multiple dosage forms, all while saving time and space, results in increasingly complex and versatile equipment.

    Matt Bundenthal, director of sales and marketing for Fette Compacting America, said, “Those exploring continuous manufacturing look for equipment that is not only applicable in terms of capacity capabilities, but also integration-friendly (notably in cases where the equipment making up the full train is sourced from different suppliers).” He added, “A more general requirement is for maximum versatility in any machine. Budgets are tighter than ever and everybody wishes to have tablet presses and encapsulators that can produce the greatest number of applicable dosage forms and sizes.”

    Optima Pharma develops and implements complex systems with technologies filling and closing, isolator technology and freeze drying, in central responsibility. According to Deininger of Optima, this includes digitized planning, integrated Factory Acceptance Test (iFAT), site management, Site Acceptance Test (SAT) and comprehensive services. “The Comprehensive Scientific Process Engineering (CSPE) method is used to ensure that as little time as possible elapses from order to start of production,” she said. “The combination of scientific methods and technological processes revolutionizes the planning and realization of pharmaceutical filling equipment.”

    Multiuse machines are most in demand as they process different primary packaging materials, such as vials, syringes, cartridges, including ready to use components, designed with a minimum space requirement. According to Deininger, “Users will also save time due to the adjustable transport system that does not require any format parts. A variety of technologies minimize product loss. Re-dosing upon request, short hose lines, 100%-In-Process-Control for vials, syringes and cartridges, weigh-dosing, re-capping upon request, and much more.”

    Pharma/Biopharma companies are thinking about manufacturing as well as packaging formats, particularly for biologics. Mattern of Bosch Packaging Technology, said, “New biologic developments call for flexible equipment that can handle ever smaller batches, while adapting to new products and packaging formats quickly.” He noted that pharmaceutical manufacturers are not simply looking for one machine, they’re looking for a partner who can accompany them throughout their projects. This can start as early as the R&D phase and go all the way to production and packaging, as well as include the underlying software requirements, qualification and validation support and service packages.

    “Consequently, the focus has shifted from merely technology-driven projects to complete solutions—including market expertise, innovative concepts and the flexibility to adapt to very specific and unique requirements. Such projects require a lot of time, experience and motivation,” Mattern said.

    Overcoming Challenges
    Equipment down-time tops the list of challenges that clients look to overcome. Leveraging digitization can help pharma/biopharma companies more accurately assess manufacturing operations, but implementation comes with its own set of challenges, particularly in an industry that faces strict regulatory requirements. 
Bundenthal of Fette Compacting America, said “Equipment down-time is a universal challenge—one that has led to the establishment of prevalent topics such as Overall Equipment Effectiveness (OEE). Capital equipment such as a tablet press or encapsulator represents a significant investment for any client, but especially for those fighting against thin budgets.

    It is therefore imperative to find new methods for maximizing the amount of ‘up time’ that any piece of equipment offers. Every moment that a high-speed machine sits idle represents lost opportunity and revenue.”

    Mattern, of Bosch Packaging Technology, said, “Digitization, Industry 4.0 or IoT—no matter what you want to call it, it’s all about using existing data to optimize processes, make them more transparent and more efficient. The pharmaceutical industry must overcome specific challenges compared to other industries because of the very strict regulations regarding safety and product quality.”

    In digitization projects, the first step is making the existing data visible in the first place. He explained how the digitization process works with two of Bosch’s products, “Our Pharma i 4.0 Starter Edition provides plant operators with essential data on their OEE, for condition monitoring of plant status or processes, and on important events like alarms or downtimes, in real time. The Pharma i 4.0 Starter Edition monitors single machines and several lines simultaneously. Once the data is available, data analyses, for instance Bosch’s Data Mining service, can help to identify new potential for higher production transparency and optimization.”

    Data mining makes it possible to assess information more effectively to identify and remedy the root causes of faults. He added, “In general, the data from two production batches is already sufficient to draw first conclusions. The more data that’s available for evaluation over a longer period, the more details will come to light.”

    Equipment Innovations
    With the growing number of biopharmaceuticals on the market, product and operator safety has become increasingly imperative. Equipment manufacturers have made great strides when it comes to the containment of high potent and cytotoxic compounds. Jones of PCI said, “Technology has advanced considerably in recent years, with manufacturers constantly evolving the solutions available. The area of contained engineering solutions whereby the molecules themselves are fully contained at every stage of the process, thereby reducing the risk of exposure to operators and the environment, is probably one of the most significant developments in recent years. This combined with geometrically similar equipment to aid scale-up and reproducibility has changed the way we are able to manage these often very potent molecules.” 

    Mattern of Bosch Packaging Technology, added, “In the production of oral solid dose forms (OSD), the need for small batch equipment with appropriate containment has also evolved in parallel with the high potency of the drugs.” Active Pharmaceutical Ingredients (APIs) can be classified into occupational exposure bands based on their potency. Categories are often referred to as OEB 1 (low hazard); OEB 2 (moderate hazard); OEB 3 (high hazard); OEB 4 (very high hazard); and OEB 5 (extremely high hazard). The new Bosch GKF 720 capsule filling machine has been developed for OEB 5 containment and is designed to ensure the highest protection for the operator, machine and product. Mattern added that the machine’s minimal water requirements, defective capsule detection and compact design can help with cost savings.

    According to Mattern, the development of continuous manufacturing equipment for OSD is opening new potential for optimum API dosage and faster time-to-market. Bosch recently introduced its new Xelum R&D to the market. The Xelum system doses mixes and granulates individual packages, so-called X-keys, which continuously run through the process chain and are removed successively from the machine into bins. Mattern said, “This way, even smallest amounts of APIs of less than 1% can be dosed precisely. It relies on the unique technology developed by Bosch’s subsidiary Hüttlin.

    Instead of the usual twin screw granulators, the Xelum platform works with well-established fluid bed processors for optimum granule quality.”

    Tremendous advances have been made in the area of capsule filling with respect to smaller footprints, increased yield and reduced costs. According to Bundenthal of Fette Compacting America, some of the most novel advances are servo-driven encapsulators. “By moving away from those that mechanically couple all of the sub-processes within the machine, one achieves a far greater degree of control over the entire process. Overall efficiencies can therefore increase dramatically. Some suppliers are even offering a double-sided encapsulator, which is entirely unprecedented. Such a machine can offer output of up to 400,000 capsules per hour—roughly twice that of the next fastest option,” Bundenthal said.

    While recent equipment innovations are dramatically improving manufacturing processes, demand for all encompassing flexibility continues. “Our customers increasingly wish for their machine solutions to cover a wide range of requirements: large and small batch sizes, ready to use syringes and bulk products, expensive and low-priced products, all possible container types such as syringes, vials, cartridges and special devices,” said Deininger of Optima. All this requires a high degree of flexibility and highly sophisticated solutions.
    Related Searches
    • Cancer
    • Dosage
    • Delivery Systems
    • Delivery
    Related Knowledge Center
    • Testing
    • Packaging
    • Contract Manufacturing
    Suggested For You
    Oral Solids Endure & Evolve Oral Solids Endure & Evolve
    Bone & Joint Formulas Provide Foundations for Fitness Bone & Joint Formulas Provide Foundations for Fitness
    GOED Releases Updated Omega-3 Ingredient Market Report GOED Releases Updated Omega-3 Ingredient Market Report
    FDA Plans to Modernize Dietary Supplement Regulations FDA Plans to Modernize Dietary Supplement Regulations
    Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction
    Contract Manufacturing Survey Opportunity Contract Manufacturing Survey Opportunity
    Large Meta-Analysis Backs Benefits of Probiotic for Gut Health Large Meta-Analysis Backs Benefits of Probiotic for Gut Health
    Vitamins & Minerals: Traditions in Preventive Health Vitamins & Minerals: Traditions in Preventive Health
    GOED Updates Voluntary Monograph with Lower Lead Limit GOED Updates Voluntary Monograph with Lower Lead Limit
    Prebiotic Ingredients Market to Reach Nearly $7.7 Billion by 2025 Prebiotic Ingredients Market to Reach Nearly $7.7 Billion by 2025
    Botanical Adulterants Prevention Program Publishes Cranberry Laboratory Guidance Document Botanical Adulterants Prevention Program Publishes Cranberry Laboratory Guidance Document
    The Clean Label Tidal Wave: Dosage Delivery Forms Become Critical The Clean Label Tidal Wave: Dosage Delivery Forms Become Critical
    Lonza Consumer Health & Nutrition to Showcase Cutting-Edge Science & Innovation Lonza Consumer Health & Nutrition to Showcase Cutting-Edge Science & Innovation
    Technical Information: The Use of EMDEX® in a Lactose-free Reformulation of Cetirizine Tablets Technical Information: The Use of EMDEX® in a Lactose-free Reformulation of Cetirizine Tablets
    Is Google’s AdSense System Biased Against Dietary Supplements? Is Google’s AdSense System Biased Against Dietary Supplements?

    Related Content

    • Contract Manufacturing | Delivery & Dosage Technologies | World Markets
      Oral Solids Endure & Evolve

      Oral Solids Endure & Evolve

      Contract service providers discuss the state of the oral solid dose development and manufacturing market.
      By Tim Wright, Editor, Contract Pharma 03.01.19

    • Bone & Joint Health | Dietary Supplements | Functional Foods & Beverages | Healthy Aging | Herbs & Botanicals | Inflammation | Nutrition Bars & Snacks | Proteins, Peptides, Amino Acids | Research | Sports Nutrition | Vitamins
      Bone & Joint Formulas Provide Foundations for Fitness

      Bone & Joint Formulas Provide Foundations for Fitness

      Nutritional products aim to elevate consumer performance, mobility, and recovery.
      By Lisa Olivo, Associate Editor 03.01.19

    • Breaking News | Industry & Market News | Marine Nutraceuticals | Omega-3s
      GOED Releases Updated Omega-3 Ingredient Market Report

      GOED Releases Updated Omega-3 Ingredient Market Report

      Analysis details 2016 and 2017 volume and value of the raw materials sector of the global omega-3 sector.
      02.15.19


    • Dietary Supplements | Quality & Safety | Regulations
      FDA Plans to Modernize Dietary Supplement Regulations

      FDA Plans to Modernize Dietary Supplement Regulations

      Agency seeks to balance consumer access to safe, lawful products while promoting industry innovation.
      By Sean Moloughney, Editor 02.12.19

    • Breaking News | Enzymes | Natural/Organic | Nutrition Bars & Snacks | Supplier News
      Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction

      Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction

      Acryleast effective in reducing levels by up to 90% without impact on taste or texture.
      01.29.19

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      Breaking News
      • Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
      • Coca-Cola to Phase Out Honest Tea Brand by Year’s End, Citing Supply Chain Challenges
      • Vitafoods Europe 2022 Attendance Returns to 2019 Level
      • Beyond Raw Launches Concept X Pre-Workout Line
      • Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Coca-Cola to Phase Out Honest Tea Brand by Year’s End, Citing Supply Chain Challenges
      Vitafoods Europe 2022 Attendance Returns to 2019 Level
      Beyond Raw Launches Concept X Pre-Workout Line
      Coatings World

      Latest Breaking News From Coatings World

      PPG Sets Goals to Reduce Greenhouse Gas Emissions, Unveils 2021 ESG Report
      Birla Carbon to Present Sustainable Carbon-based Solutions at PaintIndia 2022
      BTC Europe, NXTLEVVEL Biochem to Distribute Biobased & Biodegradable Solvents in Europe
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Kilo Health Invests 500,000 Euros in Pulsetto
      China to Strengthen Robotic Surgical Market With Second 5-Year Plan
      First Patient Enrolled in Alucent Biomedical's Vascular Scaffolding Clinical Trial
      Contract Pharma

      Latest Breaking News From Contract Pharma

      A Clean Sweep for AES at FOYA Awards
      Lonza, IBF Partner on Drug Development, Manufacture for Portfolio Cos
      INCOG BioPharma Services Opens Biomanufacturing Facility
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Estée Lauder Promotes Gibu Thomas to EVP, ELC Online
      HipDot Launches Girl Scout Cookie Collection
      L’Oréal Invests in Japanese Beauty Startup, Sparty
      Happi

      Latest Breaking News From Happi

      Croda Achieves Highest Carbon Management Level in Ecovadis’ New Carbon Scorecard
      OleHenriksen’s “Big Oh Duo” Pairs New Body Skincare and Sexual Wellness Device
      Crown Laboratories Expands Aesthetics Stable with Acquisition of Med Device Company
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Zeller+Gmelin, Sun Chemical and Kornit Top This Week’s News
      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Rotocon wins AI Business Excellence Award
      Quad adds Landa S10P Nanographic Printing Press
      Sihl launches materials for on-demand color label printing
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Thinx Names Meghan Davis as CEO
      Kimberly-Clark Reportedly Examining Sale of Latin American Tissue
      Ahlstrom-Munksjö Announces Reorganization of Decor Business Ownership
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      James W. Stone Named AANA President
      Tom Hedman Named Senior Principal Scientist at Spinal Simplicity
      ODT's Most Read Stories This Week—May 21
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Graphene Flagship, Japan Display and LG Display Top This Week’s Stories
      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login